Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Breast cancer targeting through inhibition of the endoplasmic reticulum-based apoptosis regulator Nrh/BCL2L10.

Nougarede A, Popgeorgiev N, Kassem L, Omarjee S, Borel S, Mikaelian I, Lopez J, Gadet R, Marcillat O, Treilleux I, Villoutreix BO, Rimokh R, Gillet G.

Cancer Res. 2018 Jan 12. pii: canres.0846.2017. doi: 10.1158/0008-5472.CAN-17-0846. [Epub ahead of print]

PMID:
29330143
2.

Relationship of Human Immunodeficiency Virus Viral Load in Cerebrospinal Fluid and Plasma in Patients Co-infected With Cryptococcal Meningitis.

Chang CC, Kangethe R, Omarjee S, Hiramen K, Gosnell B, Sojane K, Moosa MS, Lewin SR, French MA, Ndung'u T.

Open Forum Infect Dis. 2017 Feb 12;4(2):ofx032. doi: 10.1093/ofid/ofx032. eCollection 2017 Spring.

3.

The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer.

Omarjee S, Jacquemetton J, Poulard C, Rochel N, Dejaegere A, Chebaro Y, Treilleux I, Marangoni E, Corbo L, Romancer ML.

Oncogene. 2017 May 4;36(18):2503-2514. doi: 10.1038/onc.2016.415. Epub 2016 Dec 12.

4.

Long-term exposure to bisphenol A or benzo(a)pyrene alters the fate of human mammary epithelial stem cells in response to BMP2 and BMP4, by pre-activating BMP signaling.

Clément F, Xu X, Donini CF, Clément A, Omarjee S, Delay E, Treilleux I, Fervers B, Le Romancer M, Cohen PA, Maguer-Satta V.

Cell Death Differ. 2017 Jan;24(1):155-166. doi: 10.1038/cdd.2016.107. Epub 2016 Oct 14.

5.

Genetic determinants of Nef-mediated CD4 and HLA class I down-regulation differences between HIV-1 subtypes B and C.

Mann JK, Omarjee S, Khumalo P, Ndung'u T.

Virol J. 2015 Nov 25;12:200. doi: 10.1186/s12985-015-0429-7.

6.

Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: association with disease progression and influence of immune pressure.

Mann JK, Chopera D, Omarjee S, Kuang XT, Le AQ, Anmole G, Danroth R, Mwimanzi P, Reddy T, Carlson J, Radebe M, Goulder PJ, Walker BD, Abdool Karim S, Novitsky V, Williamson C, Brockman MA, Brumme ZL, Ndung'u T.

Virology. 2014 Nov;468-470:214-25. doi: 10.1016/j.virol.2014.08.009. Epub 2014 Sep 3.

7.

The fitness landscape of HIV-1 gag: advanced modeling approaches and validation of model predictions by in vitro testing.

Mann JK, Barton JP, Ferguson AL, Omarjee S, Walker BD, Chakraborty A, Ndung'u T.

PLoS Comput Biol. 2014 Aug 7;10(8):e1003776. doi: 10.1371/journal.pcbi.1003776. eCollection 2014 Aug.

8.

Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection.

Naranbhai V, Chang CC, Durgiah R, Omarjee S, Lim A, Moosa MY, Elliot JH, Ndung'u T, Lewin SR, French MA, Carr WH.

AIDS. 2014 Mar 13;28(5):657-66. doi: 10.1097/QAD.0000000000000200.

9.

Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.

Mann JK, Byakwaga H, Kuang XT, Le AQ, Brumme CJ, Mwimanzi P, Omarjee S, Martin E, Lee GQ, Baraki B, Danroth R, McCloskey R, Muzoora C, Bangsberg DR, Hunt PW, Goulder PJ, Walker BD, Harrigan PR, Martin JN, Ndung'u T, Brockman MA, Brumme ZL.

Retrovirology. 2013 Sep 16;10:100. doi: 10.1186/1742-4690-10-100.

10.

No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.

Chopera DR, Mann JK, Mwimanzi P, Omarjee S, Kuang XT, Ndabambi N, Goodier S, Martin E, Naranbhai V, Karim SA, Karim QA, Brumme ZL, Ndung'u T, Williamson C, Brockman MA; CAPRISA 004 TRAPS Team.

PLoS One. 2013 Aug 28;8(8):e71758. doi: 10.1371/journal.pone.0071758. eCollection 2013.

11.

Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome.

Chang CC, Omarjee S, Lim A, Spelman T, Gosnell BI, Carr WH, Elliott JH, Moosa MY, Ndung'u T, French MA, Lewin SR.

J Infect Dis. 2013 Nov 15;208(10):1604-12. doi: 10.1093/infdis/jit388. Epub 2013 Aug 1.

12.

Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy.

Chang CC, Lim A, Omarjee S, Levitz SM, Gosnell BI, Spelman T, Elliott JH, Carr WH, Moosa MY, Ndung'u T, Lewin SR, French MA.

J Infect Dis. 2013 Sep;208(6):898-906. doi: 10.1093/infdis/jit271. Epub 2013 Jun 12.

13.

Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.

Chang CC, Dorasamy AA, Gosnell BI, Elliott JH, Spelman T, Omarjee S, Naranbhai V, Coovadia Y, Ndung'u T, Moosa MY, Lewin SR, French MA.

AIDS. 2013 Aug 24;27(13):2089-99. doi: 10.1097/QAD.0b013e3283614a8d.

PMID:
23525034
14.

Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design.

Ferguson AL, Mann JK, Omarjee S, Ndung'u T, Walker BD, Chakraborty AK.

Immunity. 2013 Mar 21;38(3):606-17. doi: 10.1016/j.immuni.2012.11.022.

Supplemental Content

Loading ...
Support Center